NABI Biopharmaceuticals
- Stock Issuer and Owners
NABI Biopharmaceuticals |
Ticker | VXRT |
CIK # | 0000072444 |
CUSIP | 92243A200 |
Sector | Life Sciences - Biological Products, (No Disgnostic Substances) |
Address | 12276 Wilkins Avenue, Rockville, MD 20852 |
Source |
[EDGAR]
|
Form 13F Holdings |
Firm |
Period |
DFND |
Voting |
Shares |
BlackRock Inc. |
[2023-03-31]
|
SOLE |
8,671,669.0 |
8,818,647.0 |
Vanguard Group Inc |
[2023-03-31]
|
SOLE |
0.0 |
6,926,711.0 |
Geode Capital Management LLC |
[2023-03-31]
|
DFND |
2,662,473.0 |
2,662,473.0 |
State Street Corp |
[2023-03-31]
|
DFND |
2,536,929.0 |
2,653,619.0 |
Nuveen Asset Management LLC |
[2023-03-31]
|
DFND |
2,219,532.0 |
2,219,532.0 |
Two Sigma Investments LP |
[2023-03-31]
|
SOLE |
1,194,023.0 |
1,194,023.0 |
Northern Trust Corp |
[2023-03-31]
|
DFND |
16,014.0 |
1,122,388.0 |
Two Sigma Advisers LP |
[2023-03-31]
|
SOLE |
1,074,200.0 |
1,099,500.0 |
Charles Schwab Investment Management Inc |
[2023-03-31]
|
SOLE |
993,223.0 |
993,223.0 |
D. E. Shaw & Co., Inc. |
[2023-03-31]
|
DFND |
970,590.0 |
981,383.0 |
Citadel Advisors LLC |
[2023-03-31]
|
DFND |
735,750.0 |
735,750.0 |
Morgan Stanley |
[2023-03-31]
|
DFND |
457,269.0 |
502,941.0 |
Bank of New York Mellon Corp |
[2023-03-31]
|
DFND |
378,131.0 |
449,046.0 |
Bank of America Corp /DE/ |
[2023-03-31]
|
DFND |
24,271.0 |
309,176.0 |
IHT Wealth Management LLC |
[2023-03-31]
|
SOLE |
442.0 |
261,223.0 |
Raymond James Financial Services Advisors Inc |
[2023-03-31]
|
SOLE |
0.0 |
212,004.0 |
RhumbLine Advisers |
[2023-03-31]
|
SOLE |
79,877.0 |
192,078.0 |
AllianceBernstein LP |
[2023-03-31]
|
DFND |
191,100.0 |
191,100.0 |
Ergoteles LLC |
[2023-03-31]
|
SOLE |
168,791.0 |
168,791.0 |
Deutsche Bank AG |
[2023-03-31]
|
DFND |
95,652.0 |
155,995.0 |
Goldman Sachs Group Inc |
[2023-03-31]
|
DFND |
139,402.0 |
139,402.0 |
Vanguard Group Inc |
[2023-03-31]
|
DFND |
0.0 |
137,175.0 |
Private Portfolio Partners LLC |
[2023-03-31]
|
SOLE |
0.0 |
108,970.0 |
Point72 Asset Management LP |
[2023-03-31]
|
DFND |
0.0 |
103,039.0 |
Price T Rowe Associates Inc /MD/ |
[2023-03-31]
|
DFND |
101,980.0 |
101,980.0 |
JPMorgan Chase & Co |
[2023-03-31]
|
DFND |
450.0 |
98,951.0 |
Susquehanna International Group LLP |
[2023-03-31]
|
DFND |
72,279.0 |
98,679.0 |
New York State Common Retirement Fund |
[2023-03-31]
|
SOLE |
77,529.0 |
77,529.0 |
Millennium Management LLC |
[2023-03-31]
|
SOLE |
75,872.0 |
75,872.0 |
Invesco Ltd. |
[2023-03-31]
|
DFND |
0.0 |
72,586.0 |
Prev | Page 1 | Next
|
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "update_card": "/update-card"}
{"uid": 124831979, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 0, "random_n": 0}
False
171255114